1.
B Lymphocytes in obesity-related adipose tissue inflammation and insulin resistance
by Winer, Daniel A
Cellular and molecular life sciences : CMLS, 2013, Vol.71 (6), p.1033-1043
2.
B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies
by Winer, Daniel A
Nature medicine, 2011, Vol.17 (5), p.610-617
3.
Pten deletion in RIP-Cre neurons protects against type 2 diabetes by activating the anti-inflammatory reflex
by Wang, Linyuan
Nature medicine, 2014, Vol.20 (5), p.484-492
4.
B Lymphocytes Promote Insulin Resistance through Modulation of T Lymphocytes and Production of Pathogenic IgG Antibody
by Winer, Daniel A. Daniel A.
Nature medicine, 2011, Vol.17 (5), p.610-617
5.
Normalization of obesity-associated insulin resistance through immunotherapy
by Chan, Yin
Nature medicine, 2009, Vol.15 (8), p.921-929
6.
Progestogens Used in Postmenopausal Hormone Therapy: Differences in Their Pharmacological Properties, Intracellular Actions, and Clinical Effects
by Stanczyk, Frank Z
Endocrine reviews, 2013, Vol.34 (2), p.171-208
7.
Palbociclib with adjuvant endocrine therapy in early breast cancer (PALLAS): interim analysis of a multicentre, open-label, randomised, phase 3 study
by Mayer, Erica L
The lancet oncology, 2021, Vol.22 (2), p.212-222
8.
Combination inhibition of PI3K and mTORC1 yields durable remissions in mice bearing orthotopic patient-derived xenografts of HER2-positive breast cancer brain metastases
by Ni, Jing
Nature medicine, 2016, Vol.22 (7), p.723-726
9.
Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retro...
by Albain, Kathy S, Prof
The lancet oncology, 2010, Vol.11 (1), p.55-65
10.
Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials
by Asselain, Bernard
The lancet oncology, 2018, Vol.19 (1), p.27-39
11.
Primary Sjögren's syndrome and deficiency of ICA69
by Winer, Shawn
The Lancet (British edition), 2002, Vol.360 (9339), p.1063-1069
12.
Normalization of Obesity-Associated Insulin Resistance through Immunotherapy: CD4+ T Cells Control Glucose Homeostasis
by Winer, Shawn Shawn
Nature medicine, 2009, Vol.15 (8), p.921-929
13.
Fibroblast Growth Factor Receptors as Molecular Targets in Thyroid Carcinoma
by St. Bernard, Rosanne
Endocrinology (Philadelphia), 2005, Vol.146 (3), p.1145-1153
14.
Combination inhibition of PI3K and mTORC1 yields durable remissions in orthotopic patient-derived xenografts of HER2-positive breast cancer brain metastases
by Ni, Jing Jing
Nature medicine, 2016, Vol.22 (7), p.723-726
15.
16.
Inability to escalate vinorelbine dose intensity using a daily x3 schedule with and without filgrastim in patients with metastatic breast cancer
by HAVLIN, K. A
Cancer chemotherapy and pharmacology, 1999, Vol.43 (1), p.68-72
17.
Inability to escalate vinorelbine dose intensity using a daily × 3 schedule with and without filgrastim in patients with metastatic breast cancer
by Havlin, Kathleen A.
Cancer chemotherapy and pharmacology, 1999, Vol.43 (1), p.68-72
18.
Dynamics of consumer preferences
by Morwitz, Vicki G
Marketing letters, 1997, Vol.8 (1), p.55-152
19.
Special issue on choice theory
by Ben-Akiva, Moshe
Marketing letters, 1997, Vol.8 (3), p.273-375
